FDA Inspection 903061 — ARSCI INC.

ARSCI INC. — FEI 3007293046

The FDA completed an inspection of ARSCI INC. on October 30, 2014 in Longueuil. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 15 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
October 30, 2014
Fiscal Year
2015
Product Type
Devices
Project Area
Compliance: Devices
Location
Longueuil (Canada)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
235021 CFR 820.25(b)Training - Lack of or inadequate procedures
237121 CFR 820.30(a)Design control - no procedures
312021 CFR 820.80(a)Lack of or inadequate procedures - Acceptance activities
313021 CFR 820.100(a)Lack of or inadequate procedures
313221 CFR 820.120Lack of or inadequate procedures for labeling
316021 CFR 820.184Lack of or inadequate DHR procedures
323321 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
326421 CFR 820.250(b)Sampling methods - Lack of or inadequate procedures
328621 CFR 820.90(b)(1)Procedures for product review,disposition lack of/inadequate
333121 CFR 820.181DMR - not or inadequately maintained
368021 CFR 820.70(a)Process control procedures, Lack of or inadequate procedures
53921 CFR 820.70(b)Production and Process Change Procedures, lack of or Inad.
54621 CFR 820.75(a)Lack of or inadequate process validation